PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40627448,NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.,2025-Jul-08,"Nabet, BY; Gayevskiy, V; Shames, DS","Genentech Inc., South San Francisco, United States of America.; Genentech Inc., South San Francisco, United States of America.; Genentech Inc., South San Francisco, United States of America.",
40624835,"Drugging the 'undruggable' KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer.",2025-Jul-07,"Zhou, W","Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi 830017, China.",
40623718,"Authors response to ""Letter to the Editor"": ""Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types"".",2025-Jul-07,"Graf, RP","Foundation Medicine Inc, San Diego, California, USA rgraf@foundationmedicine.com.",rgraf@foundationmedicine.com
40622253,Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice.,2025-Jul-07,"Khan, MJ; Lee, YJ; Lee, SY; Kang, YM","Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.; Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.",
40621477,Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells.,2025-Jun-12,"Allan, DSJ; Childs, RW","Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, NHLBI, NIH, Bethesda, MD 20892, USA.; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, NHLBI, NIH, Bethesda, MD 20892, USA.",
40620658,Combining antigen specific T-cells with T-cell engager therapy induces a molecular signature that favors T-cell fitness.,2025-Jun,"Oelke, M; Kim, S; Wang, R; Ragheb, JA",NexImmune Inc.; NexImmune Inc.; NexImmune Inc.; NexImmune Inc.,
